Table 3.

Diagnostic performance of a biomarker panel for DLB versus other clinical groups

DLB versus	Accuracy (95% CI)	Sensitivity (95% CI)	Specificity (95% CI)
All non-DLB	0.82 (0.75–0.89)	0.69 (0.41–0.98)	0.83 (0.74–0.90)
Controls	0.84 (0.77–0.89)	0.77 (0.46–1.00)	0.85 (0.76–0.93)
PD	0.79 (0.69–0.87)	0.72 (0.43–0.93)	0.80 (0.66–0.90)
AD	0.89 (0.85–0.99)	0.85 (0.79–0.99)	1.00 (1.00–1.00)
FTD	0.76 (0.61–0.92)	0.73 (0.55–0.95)	0.86 (0.59–1.00)

All protein levels were Z transformed according to the mean and standard deviation in controls

Abbreviations: AD Alzheimer’s disease, DLB Dementia with Lewy bodies, FTD Frontotemporal dementia, PD Parkinson’s disease